Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10138221 Salts of nilotinib and polymorphs thereof

Patent 10138221 was granted and assigned to Sun Pharmaceutical on November, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 21 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12064430 Kinase inhibitor salts and compositions thereof
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12064428 Kinase inhibitor salts and compositions thereof
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+304 characters)
Article

Patent abstract

The present invention provides novel salts of nilotinib and polymorphs thereof. The acid addition salts of nilotinib with benzenesulfonic acid, butanedisulfonic acid, 1-5-naphthalenedisulfonic acid, naphthalene-1-sulfonic acid and 1-hydroxynaph-thoic acid; hydrates and anhydrates thereof.

Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Sun Pharmaceutical
Sun Pharmaceutical
0
Current Assignee
Sun Pharmaceutical
Sun Pharmaceutical
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101382210
Date of Patent
November 27, 2018
0
Patent Application Number
155031440
Date Filed
August 10, 2015
0
Patent Citations Received
‌
US Patent 10940149 Kinase inhibitor salts and compositions thereof
0
‌
US Patent 11007195 Kinase inhibitor salts, and compositions thereof
0
‌
US Patent 11052088 Kinase inhibitor salts, and compositions thereof
0
Patent Primary Examiner
‌
Alexander R Pagano
0
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 21 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 21 Mar, 2023
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Sun Pharmaceutical
Sun Pharmaceutical
0
Current Assignee
Sun Pharmaceutical
Sun Pharmaceutical
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101382210
Date of Patent
November 27, 2018
0
Patent Application Number
155031440
Date Filed
August 10, 2015
0
Patent Citations Received
‌
US Patent 10940149 Kinase inhibitor salts and compositions thereof
0
‌
US Patent 11007195 Kinase inhibitor salts, and compositions thereof
0
‌
US Patent 11052088 Kinase inhibitor salts, and compositions thereof
0
Patent Primary Examiner
‌
Alexander R Pagano
0
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11052088 Kinase inhibitor salts, and compositions thereof
Edits on 11 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11007195 Kinase inhibitor salts, and compositions thereof
Edits on 10 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10940149 Kinase inhibitor salts and compositions thereof
Edits on 23 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 23 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10138221 Salts of nilotinib and polymorphs thereof

Infobox
Is a
Patent
Patent
Patent applicant
Sun Pharmaceutical
Sun Pharmaceutical
Current assignee
Sun Pharmaceutical
Sun Pharmaceutical
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10138221
Date of patent
November 27, 2018
Patent application number
15503144
Date Filed
August 10, 2015
Patent primary examiner
‌
Alexander R Pagano

Find more entities like US Patent 10138221 Salts of nilotinib and polymorphs thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.